Amendment to NICE guideline on anxiety

The National Institute for Health and Clinical Excellence (NICE) has today issued an amendment to the guidelines on the management of depression and anxiety in primary and secondary care. The guidance, originally published in December 2004, has been updated following safety advice issued by the MHRA on the prescription of venlafaxine.